Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report

Gut

Volumn 41, Issue 1, 1997, Pages 8-13

  Malfertheiner, P ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBODY; ANTIINFECTIVE AGENT; BISMUTH CITRATE; CARBON 13; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; TETRACYCLINE; TINIDAZOLE; UREA;

ARTICLE; BIOPSY; BLEEDING; BREATH ANALYSIS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DYSPEPSIA; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MEDICAL SPECIALIST; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTICENTER STUDY; PATIENT CARE; PEPTIC ULCER; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SEROLOGY;

EID: 0030877226     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.1.8     Document Type: Article

References (50)

1. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9.
2. Breuer T, Malaty HM, Goodman K, Sudhop T, Graham DY. Treatment regime used in Helicobacter pylori positive ulcer disease; a nationwide comparison of gastroenterologists and family practitioners in the USA [abstract]. Gut 1996; 39 (suppl 2): A22.
3. Penston JG, Mistry KR. Eradication of Helicobacter pylori in general practice. Aliment Pharmacol Ther 1996; 10: 1 39-45.
4. Valori RM, Brown CM, Strangeways P. Community dyspepsia workshops reduce dyspepsia drug costs [abstract]. Gut 1996; 38 (suppl 1): A34.
5. Bell GD, Powell KU, Burridge SM, Bowden AF, Atoyebi W, Bolton GH, et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9: 41-6.
6. Heikkinen M, Pikkarainen P, Takala J, Räsänen H, Julkunen R. Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 1995; 30: 519-23.
7. Feldman RA, Deeks JJ, Evans SJ, Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Helicobacter pylori Serology Study Group. Eur J Clin Microbiol Infect Dis 1995; 14: 428-33.
8. Peitz U, Labenz J, Tillenburg, Baumann M, Borsch G. Validity of a new whole blood test for Helicobacter pylori infection [abstract]. Gut 1995; 37 (suppl 2): A107.
9. Duggan AE, Knifton A, Logan RPH, Hawkey CJ, Logan RFA. Validation of two new blood tests for Helicobacter pylori [abstract]. Gut 1995; 37 (suppl 2): A85.
10. Casale V, Stigliano V, Abbolito MR, Fracasso P, Grassi A, Lapenta R. Diagnosis of Helicobacter pylori active infection in symptomatic patients by a new rapid serological test [abstract]. Gut 1995; 37 (suppl 2): A205.
11. Breslin NP, Flynn S, Balbirnie E, O'Morain C. Validation of an "office" serological test for Helicobacter pylori [abstract]. Gastroenterology 1996; 110: A68.
12. Estève J, Kricker A, Ferlay J, Parkin DM in collaboration with the Steering Committee of the European Network of Cancer Registries. Facts and figures of cancer in the European Community 1993. Lyon, International Agency for Research on Cancer, 1993.
13. Tham TCK, McLaughlin N, Hughes DF, Ferguson M, Crosbie JJ, Madden MM, et al. Possible role of Helicobacter pylori serology in reducing endoscopy workload. Postgrad Med J 1994; 70: 809-12.
14. Collins JSA, Bamford KB, Sloan JM, Collins BJ, Moorehead RJ, Love AHG, et al. Screening for Helicobacter pylori antibody could reduce endoscopy workload in young dyspeptic patients. Eur J Gastroenterol Hepatol 1992; 4: 991-3.
15. Sobala GM, Crabtree JE, Pentith JA, Rathbone BJ, Shallcross TM, Wyatt JI, et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991; 338: 94-6
16. Breslin N, Lee J, Buckley M, O'Morain C. Screening of young dyspeptics - an alternative hypothesis. Ir J Med Sci 1996; 165 (suppl 4): 16.
17. Patel P, Khulisi S, Mendall MA, Lloyd R, Jazrawi R, Mawell JD, et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet 1995; 346: 1315-8.
18. Sonnenberg A. Cost benefit analysis of testing for Helicobacter pylori in dypeptic patients. Am J Gastroenterol 1996; 91: 1773-7.
19. Briggs AH, Sulpher MJ, Logan RPH, Aldous J, Ramsay ME, Baron JH. Cost-effectiveness of screening for Helicobacter pylori in management of dyspeptic patients under 45 years of age. BMJ 1996; 312: 1321-5.
20. Fendrick AM, Chernew ME, Hirsh RA, Bloom BS. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995; 123: 260-8.
21. Buckley M, Xia H, Hyde D, O'Morain C. Cost effective, European approach to Heicobacter pylori eradication [abstract]. Gut 1995; 37 (suppl 2): A175.
22. Lamouliatte H, Cayla R, Zerbils F, Talbi P, Mégraud F. Triple therapy using proton pump inhibitor, amoxycillin and clarithromycin for Helicobacter pylori eradication [abstract]. Gut 1995; 37 (suppl 2): A151.
23. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996; 20: 1161-81.
24. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110: 1244-52.
25. Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993; 28: 939-42.
26. Labenz J, Börsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19-23.
27. Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995; 41: 1-4.
28. Phull PS, Ryder SD, Halliday D, Price AB, Levi AJ, Jacyna M. The economic and quality of life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease - a community based study. Postgrad Med J 1995; 71: 413-8.
29. Kosunen TU, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992; 339: 893-5.
30. Ferrana M, Vianello F, Basso D, Leandro G, DalBo N, Salandin S, et al. Serological tests for diagnosing Helicobacter pylori eradication [abstract]. Gut 1995; 37 (suppl 2): A195.
31. Buckley N, O'Morain C. Helicobacter pylori eradication - a surrogate marker for duodenal ulcer healing. Eur J Gastroenterol Hepatol 1996; 8: 415-6.
32. Miehlke S, Bayerdörffer E, Lehn N, Mannes GA, Höchter W, Weingart J, et al. Recurrence of duodenal ulcer during five years of follow-up after cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995; 7: 975-8.
33. Labenz J, Tillenburg B, Peitz U, Börsch G. Long-term consequences of Helicobacter pylori eradication: clinical aspects. Scand J Gastroenterol 1996; 31 (suppl 215): 111-5.
34. Lee YT, Chan FKL, Sung JY, Leung VKS, To KF, Yung MF, et al. Prevention of NSAID-induced ulcer by eradication of H. pylori. A prospective randomized study [abstract]. Gut 1996; 39 (suppl 2): A26.
35. Ng TM, Fock KM, Khor JL, Teo EK, Chia SC. Helicobacter pylori and NSAIDs in bleeding gastric ulcer [abstract]. Gut 1996; 39 (suppl 2): A2.
36. Bayerdörffer E, Neubauer A. Helicobacter pylori und Magenlymphom. In: Malfertheiner P, Hrsg. Helicobacter pylori - Von der Grundlage zur Therapie. Stuttgart, New York: Thieme 1996, 97-107.
37. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, et al. Helicobacter pylon eradication inhibits the growth of intestinal type of gastric cancer in initial stage [abstract]. Gastroenterology 1996; 110: A130.
38. Talley NJ. A critique of therapeutic trials in Helicobacter pylori positive functional dyspepsia. Gastroenterology 1994; 1174-83.
39. McCarthy C, Patchett S, Collins RM, Beattie S, Keane C, O'Morain C. Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci 1995; 40: 114-9.
40. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HPM, Liedman B, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334: 1018-22.
41. Unge P. Review of Helicobacter pylori eradication regimens. Scand J Gastroenterol 1996; 31 (suppl 215): 74-81.
42. Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Simoni P, et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 773-7.
43. Bell GD, Powell KU, Burridge SM, Bowden AF, Atoyebi W, Bolton GH, et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9: 41-6.
44. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 835-40.
45. Labenz J, Stolte M, Rühl GH, Becker T, Tillenburg B, Sollbohmer M, et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995; 7: 9-11.
46. Jaup BH, Norby A. Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol 1995; 90: 943-5.
47. Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdörffer E, O'Morain C, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 study. Helicobacter 1996: 1: 138-44.
48. Misiewicz, JJ, Harris AW, Bardhan KD, Levi S, Langworthy H. One week low-dose triple therapy for eradication of H. pylori: a large multicentre, randomised trial [abstract]. Gastroenterology 1996; 110: A198.
49. Labenz J, Tillenburg B, Weismüller J, Lütke A, Stolte M. Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylon infection in patients with duodenal ulcer. Aliment Pharmacol Ther 1997; in press.
50. Labenz J, Peitz U, Tillenburg B, Becker T, Börsch G, Stolte M. Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for eradication of Helicobacter pylori. Leber Magen Darm 1995; 25: 122-7.